Persivia vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $107M strategic (May 2025) from Aldrich Capital. 200+ hospitals, 12,000+ clinicians. Patented Soliton AI engine. Global expansion in 2026. Spans care management, population health, and RCM.
About
Persivia is a unified AI healthcare platform spanning care management, population health analytics, and revenue cycle operations — one of the few integrated platforms that addresses both the clinical and financial sides of health system performance simultaneously. The company raised $107 million in strategic financing from Aldrich Capital Partners in May 2025, and is actively expanding globally in 2026 with its CareSpace platform deployed at 200+ hospitals and used by 12,000+ clinicians.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.